The HTA body of the Tuscany Regional Healthcare issues three types of documents: full HTA reports, rapid HTA reports, and motivational forms. With regional decree 24486 of December 7, 2022, Tuscany Regional Healthcare has published assessments of three medical devices in the surgical procedures, neurology and neurosurgery, and extracorporeal treatments areas.
Below is the list of technologies that have been assessed:
- Mixed composition mesh DynaMesh - IPST by FEG Textiltechnik, for surgical treatment of parastomal hernias;
- Tumor treating field (TTF) OPTUNE (NOVOTTF-200A) by Novocure for patients with newly diagnosed glioblastoma multiforme after surgery and radiotherapy with adjuvant temozolomide in combination with maintenance temozolomide;
- TransMedics Organ Care System (OCS) Heart by TransMedics, a portable system for perfusion and monitoring of the heart.
See the regional decree and all assessments in Italian here.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).
Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.